
Thomas C. Diaz
Examiner (ID: 5729, Phone: (571)270-5461 , Office: P/3656 )
| Most Active Art Unit | 3656 |
| Art Unit(s) | 3617, 3656, 3682 |
| Total Applications | 1182 |
| Issued Applications | 780 |
| Pending Applications | 84 |
| Abandoned Applications | 349 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17704523
[patent_doc_number] => 20220204529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHOD FOR PREPARING LORNOXICAM
[patent_app_type] => utility
[patent_app_number] => 17/383493
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383493 | Method for preparing lornoxicam | Jul 22, 2021 | Issued |
Array
(
[id] => 18077290
[patent_doc_number] => 20220402902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => BICYCLIC COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/378957
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378957
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378957 | Bicyclic compound and use thereof | Jul 18, 2021 | Issued |
Array
(
[id] => 17428290
[patent_doc_number] => 20220055998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => INHIBITORS OF CYCLIN-DEPENDENT KINASES
[patent_app_type] => utility
[patent_app_number] => 17/378622
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378622
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378622 | INHIBITORS OF CYCLIN-DEPENDENT KINASES | Jul 15, 2021 | Abandoned |
Array
(
[id] => 17314396
[patent_doc_number] => 20210403444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF RSV
[patent_app_type] => utility
[patent_app_number] => 17/370586
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370586 | HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF RSV | Jul 7, 2021 | Abandoned |
Array
(
[id] => 18770793
[patent_doc_number] => 20230365585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/004496
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004496
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004496 | BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION | Jul 6, 2021 | Pending |
Array
(
[id] => 18163522
[patent_doc_number] => 20230030115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/367726
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367726 | RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF | Jul 5, 2021 | Pending |
Array
(
[id] => 18117498
[patent_doc_number] => 11548879
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-01-10
[patent_title] => Polycyclics as sigma receptor modulators
[patent_app_type] => utility
[patent_app_number] => 17/363042
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22726
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2052
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363042
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363042 | Polycyclics as sigma receptor modulators | Jun 29, 2021 | Issued |
Array
(
[id] => 17170283
[patent_doc_number] => 20210323953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => 1,3, 5-Dioxazine Derivatives, Method of Preparation and Application Thereof as Sulfide Scavenger
[patent_app_type] => utility
[patent_app_number] => 17/360217
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17360217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/360217 | 1,3, 5-Dioxazine Derivatives, Method of Preparation and Application Thereof as Sulfide Scavenger | Jun 27, 2021 | Abandoned |
Array
(
[id] => 17335936
[patent_doc_number] => 20220002267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => TYROSINE KINASE 2 INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/357452
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357452
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/357452 | TYROSINE KINASE 2 INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF | Jun 23, 2021 | Abandoned |
Array
(
[id] => 17168765
[patent_doc_number] => 20210322435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/355336
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17355336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/355336 | Methods of synthesis and/or purification of diaminophenothiazinium compounds | Jun 22, 2021 | Issued |
Array
(
[id] => 18628132
[patent_doc_number] => 20230286963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => CHROMENONE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS
[patent_app_type] => utility
[patent_app_number] => 18/012077
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012077
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/012077 | CHROMENONE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | Jun 21, 2021 | Abandoned |
Array
(
[id] => 18128834
[patent_doc_number] => 11555033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/351631
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 40
[patent_no_of_words] => 46172
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17351631
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/351631 | Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof | Jun 17, 2021 | Issued |
Array
(
[id] => 19142099
[patent_doc_number] => 20240140923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => Method for Preparing Key Intermediate of ABT-737 and Method for Preparing ABT-737
[patent_app_type] => utility
[patent_app_number] => 17/597868
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597868 | Method for Preparing Key Intermediate of ABT-737 and Method for Preparing ABT-737 | Jun 16, 2021 | Pending |
Array
(
[id] => 18545256
[patent_doc_number] => 11718595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/349468
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 28
[patent_no_of_words] => 45447
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349468 | Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors | Jun 15, 2021 | Issued |
Array
(
[id] => 17520442
[patent_doc_number] => 20220106291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PYRIDAZINONE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/345909
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345909 | Pyridazinone compounds and uses thereof | Jun 10, 2021 | Issued |
Array
(
[id] => 17520442
[patent_doc_number] => 20220106291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PYRIDAZINONE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/345909
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345909 | Pyridazinone compounds and uses thereof | Jun 10, 2021 | Issued |
Array
(
[id] => 17520442
[patent_doc_number] => 20220106291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PYRIDAZINONE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/345909
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345909 | Pyridazinone compounds and uses thereof | Jun 10, 2021 | Issued |
Array
(
[id] => 17520442
[patent_doc_number] => 20220106291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PYRIDAZINONE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/345909
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345909 | Pyridazinone compounds and uses thereof | Jun 10, 2021 | Issued |
Array
(
[id] => 17312764
[patent_doc_number] => 20210401812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF METABOLIC SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/344078
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344078 | Compositions for the prevention and treatment of metabolic syndrome | Jun 9, 2021 | Issued |
Array
(
[id] => 17111691
[patent_doc_number] => 20210292288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => METHOD FOR PREPARATION OF 3,7-BIS-(DIMETHYLAMINO)-PHENOTHIAZIN-5-IUM CHLORIDE OR BROMIDE
[patent_app_type] => utility
[patent_app_number] => 17/342968
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342968
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/342968 | Method for preparation of 3,7-bis-(dimethylamino)-phenothiazin-5-ium chloride or bromide | Jun 8, 2021 | Issued |